Search clinical trials for: 18F-FES PET

Total 9165 results

Nantes University Hospital

Active, not recruiting

Identification of a Biomarker Predictive of Evolution of Parkinson Disease (GLIAPARK)

Parkinson Disease

France
University of Alabama at Birmingham

Active, not recruiting

Neuroinflammation After Myocardial Infarction - Imaging Substudy

Myocardial Infarction

United States
Institute for Neurodegenerative Disorders
Biogen

Completed

Study to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS Patients

Multiple Sclerosis

United States
Memorial Sloan Kettering Cancer Center

Withdrawn

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

Histologically-confirmed Malignancies

United States
Lawson Health Research Institute
Canadian Institutes of Health Research (CIHR)

Completed

Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer (IGPC-3)

Prostate Cancer

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Completed

Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer

Prostate Cancer

Canada
University of Utah
Blue Earth Diagnostics

Terminated

[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors

Brain Tumor

United States
Nghi Nguyen
Blue Earth Diagnostics

Terminated

Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer.

Cervical Cancer | Uterine Cancer

United States
University of Texas Southwestern Medical Center

Withdrawn

Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET

Breast Cancer

United States
Istituto Clinico Humanitas
Mediolanum Cardio Research

Not yet recruiting

Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.

Glioblastoma

Italy
Shirley Ryan AbilityLab

Enrolling by invitation

Muscle Coordination-Based Feedback for Stroke Rehabilitation

Stroke

United States
Memorial Sloan Kettering Cancer Center

Completed

Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients

Head and Neck Cancer

United States
Erik Mittra
National Cancer Institute (NCI)

Terminated

18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas

Untreated Childhood Brain Stem Glioma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Oligodendroglioma | Adult Pilocytic Astrocytoma | Adult Pineal Gland Astrocytoma and other conditions

United States
Washington University School of Medicine
National Cancer Institute (NCI)

Completed

Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer

Liver Cancer

United States
National Cancer Institute (NCI)

Completed

Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1

Neurofibromatosis | MPNST

United States
National Taiwan University Hospital

Recruiting

Establishing 18F PMPBB3 (APN 1607) PET Imaging Markers for Diagnosis of Tauopathy Parkinsonism Syndromes

Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan

Taiwan
Radboud University Medical Center

Completed

Neuroinflammation in Cognitive Decline Post-cardiac Surgery (FOCUS)

Coronary Artery Disease | Postoperative Cognitive Dysfunction | Pathophysiology

Netherlands
Stanford University

Completed

PET/MRI Evaluation of Cardiac Amyloid

Cardiac Amyloidosis

United States
Phagenesis Ltd.
NAMSA; Cytel Inc.

Recruiting

The PhINEST Study - Pharyngeal ICU Novel Electrical Stimulation Therapy (PhINEST)

Dysphagia

Finland, Switzerland, Austria, Germany
University of Saskatchewan
University of Manitoba

Terminated

Using [18F]FDOPA PET/CT to Monitor the Effectiveness of Fetal Dopaminergic Grafts in Parkinson Disease Patients

Parkinson's Disease

Canada
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease

Metastatic Head and Neck Squamous Cell Carcinoma | Metastatic Squamous Cell Carcinoma in Cervical Lymph Node

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery

Glioblastoma

United States
University of Washington

Active, not recruiting

Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy

Estrogen Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7 | Primary or Recurrent Breast Carcinoma

United States
VA Greater Los Angeles Healthcare System
Lantheus Medical Imaging

Not yet recruiting

PSMA PET Scan and mpMRI for Prostate Cancer Detection

Prostate Cancer Diagnosis

United States
National Cancer Institute (NCI)

Completed

FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer

Cervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Stage IVB Cervical Cancer

United States
Mahidol University

Completed

Efficacy of Ipomea Pes-caprae Ointment as an add-on Therapy in Patient With Jellyfish Dermatitis

Jellyfish Dermatitis | Jellyfish Venoms

Thailand
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Study of Neuroinflammation in Multiple Sclerosis by PET-MRI Imaging Using the Radiotracer ([18F]-DPA-714) : a Multicentre Cohort Study (INFLANET) (INFLANET)

Multiple Sclerosis

France
Nicole Hill
Blue Earth Diagnostics; Barrow Neurological Foundation

Recruiting

18F-Fluciclovine PET Imaging for Detecting High Grade Glioma Recurrence After Radiochemotherapy (DRARCH)

Grade III or Grade IV Glioma

United States
University of Alabama at Birmingham

Recruiting

Molecular Neuroimaging to Assess the Link Between Neuroinflammation and Cognitive Impairment in Breast Cancer

Breast Cancer

United States
Institut Cancerologie de l'Ouest
SIRIC ILIAD

Completed

[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers (EITHICS)

Triple Negative Breast Cancer

France
Columbia University

Active, not recruiting

18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer

Prostatic Neoplasms

United States
Progenics Pharmaceuticals, Inc.

Completed

Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer (CONDOR)

Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer Metastatic

United States, Canada
University of Wisconsin, Madison
National Institute on Aging (NIA)

Recruiting

Comparison of Microglial Activation in Severe Asthma and Healthy Controls (MAIA-SC)

Asthma

United States
National Cancer Centre, Singapore

Recruiting

A Novel Functional Imaging Technique With FLT-PET/MRI For Staging, Response Assessment and Radiation Treatment Planning in Cervix Cancer

Cervix Cancer | Image, Body

Singapore
Northwestern University
National Institute on Aging (NIA)

Recruiting

Tau PET Imaging in Atypical Dementias

Primary Progressive Aphasia With Suspected Alzheimer's Disease

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Suspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

United States
University of Zurich
Avid Radiopharmaceuticals; Swiss Federal Institute of Technology

Active, not recruiting

Imaging Tau Deposition in the Brain of Elderly Subjects (Add-Tau)

Healthy | Neurocognitive Disorders | Alzheimer Disease | Mild Cognitive Impairment

Switzerland
Abramson Cancer Center of the University of Pennsylvania

Completed

[18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers

Gynecologic Cancer

United States
Nottingham University Hospitals NHS Trust

Completed

[18F]HX4 PET/CT Imaging for Detection of Hypoxia (OXYPET)

Head and Neck Cancer | Lung Cancer

United Kingdom
Memorial Sloan Kettering Cancer Center

Terminated

Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer

Cervical Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer

Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8

United States
Stephen Y. Chan
National Heart, Lung, and Blood Institute (NHLBI); Bayer

Recruiting

PET Image in PAH Patients

Pulmonary Arterial Hypertension

United States
Washington University School of Medicine

Terminated

18F-FLT PET Imaging in Patients With Advanced Melanoma

Melanoma

United States
NYU Langone Health
Blue Earth Diagnostics

Recruiting

Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast Cancer

United States
Lawson Health Research Institute
Cancer Care Ontario; Centre for Probe Development and Commercialization

Recruiting

PSMA-PET Registry for Recurrent Prostate Cancer (PREP)

Recurrent Prostate Cancer

Canada
Shady Grove Fertility Reproductive Science Center
Igenomix

Unknown

Frozen Blastocyst Transfer Using Conventional Timing Versus Timing by Endometrial Receptivity Analysis (Synchrony)

Infertility, Female | Implantation Failure

United States
University College, London
Imperial College London; Cancer Research UK; National Cancer Imaging Translational...

Recruiting

[18F]FPIA PET/CT Imaging in Patients With Solid Tumours ([18F]FPIA)

Cancer | Tumor, Solid

United Kingdom
Institut Claudius Regaud

Terminated

The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane. (REVER)

HER2-positive Breast Cancer

France
Jinling Hospital, China

Not yet recruiting

To Compare the Clinical Application of 18F-LNC1007 Injection PET/CT and 18F-FDG PET/CT (18F-LNC1007)

Tumour

Search clinical trials for: 18F-FES PET

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations